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ABSTRACT
Induction of molecular proximity can mediate a
discrete functional response in biological systems.
Therefore, creating new and specific connectivity
between non-interacting proteins is a means of
imposing rational control over biological processes.
According to this principle, here we use composite
RNA aptamers to generate molecular adaptors that
link various ‘target’ molecules to a common ‘utility’
molecule, with the utility molecule being an entry
point to a pathway conscripted to process the
target molecule. In particular, we created a
bi-functional aptamer that simultaneously binds to
the green fluorescent protein (serving as a surrogate
extracellular target) and the opsonin C3b/iC3b
(serving as the utility molecule). This bi-functional
aptamer enabled us to commandeer the C3-based
opsonization-phagocytosis pathway to selectively
transport an extracellular target into the lysosome
for degradation. This novel strategy has the poten-
tial for powerful therapeutic applications with extra-
cellular proteins involved in tumor development
or surface markers on cancer cells as the target
molecules.
INTRODUCTION
Opsonization is an important immunological mechanism
of host defense, in which foreign substances are tagged by
opsonin molecules for destruction. The most important
opsonins are antibodies and complement proteins such
as C3b and its closely related fragment iC3b. These
proteins act as adaptors to connect a wide variety of
target particles with a few common receptors on eﬀector
cells such as macrophages or natural killer (NK) cells.
A major consequence of opsonization is phagocytosis,
the internalization of particles by phagocytes, which is
initiated by the receptor–opsonin interaction (1).
Compared to antibodies, however, C3b/iC3b is less
speciﬁc and has less capacity as an adaptor. The major
reason for this lies in the linkage of C3b/iC3b with the
particles it tags. Antibodies interact with their antigens
by means of non-covalent binding based on molecular
shape and charge distribution; in contrast, C3b/iC3b
uses a thioester as its ‘warhead’ for covalent attachment
to the particle being opsonized (2–5). Although C3b shows
a preference for certain hydroxyl groups, it has no intrinsic
ability to discriminate between self and non-self, and only
10% of activated C3b molecules become linked to
antigenic surfaces (6). This feature suggested the possibil-
ity of intentionally re-directing C3-based opsonization to
destroy disease-causing molecules or cells, especially those
that are not recognized by the immune system as ‘foreign’.
We explored this possibility by equipping C3b/iC3b with
an additional adaptor that provides higher speciﬁcity and
eﬃciency for the purpose of eliciting a response against a
predetermined non-natural target.
We envisioned this synthetic adaptor as a composite
bi-functional aptamer comprising at least two individual
aptamers, one for a target molecule and one for C3b/iC3b.
In this conﬁguration, the C3b/iC3b molecule and the
aptameric adaptor together would function with speciﬁcity
and eﬃciency at a similar level to that of antibodies.
Aptamers are isolated in vitro from a combinatorial
sequence pool, with speciﬁcity in target recognition
rivaling or exceeding the paratopes of antibodies (7,8).
Many aptamers can interfere with protein function and
some have been used in immunotherapies (9). Our
approach would augment the potency of target-binding
aptamers so that the targets are not merely neutralized
reversibly, but instead destroyed or damaged irreversibly.
Here we present data demonstrating the use of such a
bi-functional aptamer to mediate speciﬁc and eﬃcient
transportation of extracellular green ﬂuorescent protein
(GFP) into the lysosomes of phagocytic cells for degrada-
tion. The general strategies and principles developed in
this study are applicable to other systems. In particular,
one-time optimization of the interaction between an
aptamer and a utility molecule, such as the opsonin
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targeting many other molecules in conjunction with
aptamers developed for those other molecules.
Aptamer-mediated opsonization may cause clearance of
secreted protein targets by phagocytes, and increased
deposition of C3b/iC3b on the surface of the
target-bearing cells via aptamer binding may facilitate
cytotoxicity by phagocytes and NK cells.
MATERIALS AND METHODS
Proteins and nucleic acids
Human C3 and iC3b proteins were purchased from
Calbiochem. Human C3b protein was from Quidel. GFP
was purchased from Millipore. Azami Green, mCherry,
d2EGFP and the GFP-mCherry fusion protein were
gifts from Dr B. Shui and Dr M. Kotlikoﬀ (Cornell
University). Oligonucleotides were provided by IDT.
RNA aptamers were prepared by in vitro transcription
using the MAXIscript or MEGAshortscript T7 kit from
Ambion. Sequences of aptamers are given below.
AptC3-1:
50GGGAGAAUUCAACUGCCAUCUAGGCUAGAA
GAAUAUGACGGAUUGACCGUAUCAGGGUAGC
CGAAGGGAGACAGAAGUACUACAAGCUUCUG
GACUCGGU30.
Apt[C3-GFP]:
50GGGAGCCUGAUGGCAGGGCGAAUUGGGUGG
GGAAAGUCCUUAAAAGAGGGCCACCACAGAA
GCAAUGGGCUUCUGGACUCGGUCCCGCUCGG
CUAGAAGAAUAUGACGGAUUGACCGUAUCAG
GGUAGCCGAGC30.
AptC3-2:
50GGGAGAAUUCAACUGCCAUCUAGGCAAAUC
CGCGAGCGCCGGUACCGGUGGCGCAUGCCCAC
ACAGCACUAAACGAGUACUACAAGCUUCUGG
ACUCGGU30.
Aptamer isolation and characterization
Aptamers for C3 were isolated using protocols described
previously (10,11). Binding assays were performed in 20-ml
volumes in 1  binding buﬀer.
32P-labeled RNA probes
were prepared using [a-
32P]CTP (GE Healthcare).
A typical binding mixture with labeled RNA contained
 20fmol of RNA probe and diﬀerent amounts (usually
1–10pmol) of protein. The binding buﬀer contained
20mM Tris–HCl (pH 7.6), 150mM NaCl and 10mM
MgCl2.
The aﬃnity of aptamers to C3, C3b, or iC3b was
investigated by electrophoretic mobility shift assay
(EMSA) using 6% polyacrylamide gels (acrylamide:
bis-acrylamide, 70:1). The running buﬀer contained 10%
glycerol, 12.5mM Tris base, 100mM glycine and 2.5mM
MgCl2. Binding of the bi-functional aptamer
Apt[C3-GFP] to C3, GFP and their derivatives was deter-
mined using ﬁlter-binding assays with nitrocellulose ﬁlters
(Millipore) and a Bio-Dot SF (slot format) Microﬁltration
System (Bio-Rad).
To detect triple complex formation, 10mg of C3 protein
in 50ml of binding buﬀer (containing 50mg/ml of PMSF
and 1mg/ml of aprotinin) was immobilized on a 1cm
2
nitrocellulose ﬁlter presoaked with binding buﬀer. The
ﬁlter was blocked with 10mg/ml bovine serum albumin
(BSA) for at least 1h, and washed with binding buﬀer.
Ten micrograms of bi-functional aptamer ( 4-fold the
molar quantity of C3) was reconstituted in 100mlo f
binding buﬀer with 40U of SUPERase In (Ambion)
and incubated on the ﬁlter for at least 1h at 37 C. A
comparable amount of yeast total RNA (Ambion) was
used as a control. The ﬁlter was washed and incubated
with 5mg of GFP in 100ml of binding buﬀer, and
washed again. Proteins were eluted with 150ml of elution
buﬀer (20mM Tris–HCl pH 7.6, 750mM NaCl),
precipitated with trichloroacetic acid, and run on 6–12%
SDS–polyacrylamide gradient gels. Western blotting was
performed with rabbit anti-GFP antibody (Sigma) and the
ECL kit (GE Healthcare).
Cell culture and cell-based assays
THP-1 cells (ATCC) were maintained in RPMI-1640
medium with 10% fetal bovine serum (FBS), 100U/ml
of penicillin, 100mg/ml of streptomycin and 0.05mM
2-mercaptoethanol. For immunohistochemistry, cells
were induced to diﬀerentiate with 50ng/ml phorbol
12-myristate 13-acetate (PMA) (12,13). Each experiment
was repeated at least three times.
For the GFP internalization assays, 1mg(  10
13 mole-
cules) of Apt[C3-GFP] was reconstituted in 20mlo f
binding buﬀer (see above), heated at 70 C for 5min and
renatured at 37 C with 40U of SUPERase In. The
aptamer was mixed with  6 10
13 molecules (20mg) of
puriﬁed iC3b, followed by  10
14 molecules (10mg) of
GFP or its derivatives in 200ml of serum-free RPMI-
1640 with 0.1mg/ml of BSA and 2.5mM MgCl2 and
incubated for 30min. An additional 300ml of RPMI-
1640 was added. Approximately 2 10
6 THP-1 cells
were mixed with the prepared complex, and incubated
for 15–30min. Subsequently, the cells were washed with
15ml of RPMI-1640 three times. Live or ﬁxed (with 4%
paraformaldehyde) cells were observed and photo-
graphed using diﬀerential interference contrast (DIC)
and GFP ﬁlters with a 40  objective on a Zeiss
Axiovert microscope.
Anti-iC3b antibody (Quidel) was used to visualize iC3b
associated with THP-1 cells. The cells were prepared on a
coverslip (18 18mm) in RPMI-1640 with 50ng/ml PMA
for 2–3 days to a density of  0.5 10
5–1 10
5cells/cm
2,
then washed with pre-warmed serum-free RPMI-1640 ﬁve
times. One hundred ﬁfty microliters of protein-aptamer
mixture was added to the cells, followed by incubation
for 30min in a humid chamber at 37 C and repeated
washing in 1  PBS. Fixed cells were washed and
permeabilized with 150ml of 0.2% Triton X-100 in
1  PBS for 5min, followed by successive incubation
with anti-iC3b antibody and Alexa Fluor 594 secondary
antibody (Molecular Probes) for an hour each before pho-
tography. To visualize lysosomes in live cells, 25nM (ﬁnal
concentration) LysoTracker red DND99 (Invitrogen) was
e93 Nucleic Acids Research, 2010,Vol. 38,No. 7 PAGE 2 OF 9added to the cell suspension during endocytosis. For
bi-color detection of GFP-mCherry fusion protein, GFP
and rhodamine ﬁlters were used (14).
RESULTS
Isolation of RNA aptamers for C3 and its derivatives
Because the aptamer that recognizes C3b/iC3b serves as
the ‘utility’ moiety of the bi-functional adaptor molecule,
this aptamer must not interfere with the function of C3b/
iC3b; otherwise the receptors on the eﬀector cells might be
prevented from recognizing the complex. Aptamers are
selected according to their ability to bind to any site on
a molecule (7,8). However, review of a large number of
aptamers revealed a tendency for aptamers to ‘home’ to
active sites on the surface of a protein and inhibit the
activity of their targets (15,16). To avoid isolating inhibi-
tory aptamers for C3b/iC3b, we adopted an indirect
strategy making use of the process of C3 activation.
Native C3 is a complex and ﬂexible protein, which is
biologically inactive (17). Proteolytic cleavage of C3
causes a dramatic conformational change and yields its
active form, C3b (2–4). The prominent structural diﬀer-
ences between C3 and C3b result from this conformational
rearrangement. In addition to the activated form of the
thioester, many other binding sites are exposed through
this conversion. Subsequent proteolytic products such as
iC3b and C3c retain the major structural features of C3b
(5). Therefore, an aptamer capable of recognizing either
C3 or C3b/iC3b is unlikely to bind to the active sites
revealed only following proteolytic activation.
Based on this reasoning, we selected RNA aptamers
for C3 and tested their binding to C3b/iC3b. Using C3
as the target, we performed seven rounds of selection
and ampliﬁcation, and sequenced 54 individual clones in
the ﬁnal pool. We found that the most abundant sequence
(Figure 1A) occurred nine times, and the second
most abundant sequence occurred seven times. Both
sequences demonstrated speciﬁc binding to C3 and were
named AptC3-1 and AptC3-2, respectively. As shown in
Figure 1B, their dissociation constants as measured by
ﬁlter binding were  18nM for AptC3-1 and  20nM for
AptC3-2. The RNA–protein complexes formed by these
two aptamers showed diﬀerent mobility in an EMSA
(Figure 1C), indicating that they probably bind the C3
protein at diﬀerent sites (18). (This is also supported by
a competition assay presented in Supplementary Data.)
We subsequently tested the aﬃnity of both aptamers to
C3b and iC3b. As shown in Figure 1C, while AptC3-1 can
bind both C3b and iC3b with similar aﬃnity, AptC3-2
showed aﬃnity only to C3b. Because iC3b is the predom-
inant C3-derived opsonin in vivo (19), we decided to use
AptC3-1 as the ﬁrst utility aptamer in the bi-functional
construct. For this purpose, we mapped the regions nec-
essary for its function using deletions and mutations,
and identiﬁed a smaller portable structure as shown in
Figure 1A (see Supplementary Data for details). We also
performed a hemolytic assay and conﬁrmed that AptC3-1
did not inhibit general complement function.
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Figure 1. RNA aptamers for C3 and its derivatives. (A) Secondary
structure of full length AptC3-1 with its minimized version encircled.
This structure was predicted using the mfold program (48) and sup-
ported by mutational analyses. (B) Aﬃnity of AptC3-1 and AptC3-2
for C3 as measured by ﬁlter binding. Values represent the average
of three independent assays. Error bars indicate standard deviations.
(C) EMSA results for AptC3-1 and AptC3-2 binding to C3, C3b
or iC3b.
PAGE 3 OF 9 Nucleic AcidsResearch, 2010, Vol.38,No. 7 e93Construction of a bi-functional aptamer and
demonstration of triple-complex formation
The simplest version of a bi-functional aptameric adaptor
is composed of one targeting aptamer and one utility
aptamer. We chose the GFP as a surrogate target
molecule because its ﬂuorescent signal can be conveniently
followed by visual inspection in a functional assay to dem-
onstrate the proposed mechanism. Previously, we had
developed RNA aptamers that functionally interact with
GFP (20), including AptGFP-AP3, which binds GFP with
a Kd of 14.4nM. To construct our ﬁrst bi-functional
aptamer, we joined the minimized version of AptC3-1
with AptGFP-AP3 to form the dimeric construct
Apt[C3-GFP] depicted in Figure 2A. We then
demonstrated that both aptamers are functional in the
composite. As shown in Figure 2B, this RNA molecule
possessed the ability to bind GFP and C3b or iC3b. In
addition, Apt[C3-GFP] interacted with the GFP deriva-
tive d2EGFP, but not with Azami Green or mCherry,
ﬂuorescent proteins unrelated to GFP (21) (Figure 2B).
For the bi-functional aptamer to act as a molecular
adaptor, it must bind both ligands independently and
simultaneously. In the assay outlined in Figure 2C, we
examined the capability of C3b/iC3b, Apt[C3-GFP] and
GFP to form a stable triple complex. We ﬁrst immobilized
C3 or its derivatives on a nitrocellulose membrane and
blocked the membrane with an excess of BSA. Then
Apt[C3-GFP] and GFP were added sequentially to the
membrane. The membrane was washed extensively after
each incubation. Membrane-bound proteins were
extracted and probed with anti-GFP antibody in western
blot analysis. As shown in Figure 2D, GFP was detected
only when the bi-functional aptamer was present,
indicating that the aptameric adaptor was indeed able to
connect the two proteins.
Speciﬁc association of GFP with macrophages mediated
by the bi-functional aptamer and iC3b
We developed a cell-based functional assay to examine
whether the bi-functional aptamer could promote
speciﬁc association of GFP with macrophages in the
presence of iC3b. Analogous to the clearance of immune
complexes, this experimental system is composed of four
puriﬁed components: phagocytic cells, C3b or iC3b mole-
cules, Apt[C3-GFP] and GFP or its derivatives. To repre-
sent phagocytes, we chose the human acute monocytic
leukemia cell line THP-1 (22). This cell line expresses Fc
and C3b receptors, but lacks surface and cytoplasmic
immunoglobulins. Treatment with phorbol esters can
induce THP-1 cells to diﬀerentiate into macrophage-like
cells that adhere to tissue-culture surfaces (23). Before
using this cell line in our assays, we conﬁrmed the expres-
sion of CR3, the predominant iC3b receptor, by
immunostaining.
Because phagocytes have a natural tendency to engulf
substances added to the medium, we designed two types of
controls to demonstrate the speciﬁcity of aptamer-
mediated phagocytosis. In the ﬁrst type, one molecular
AB
None      Low      High
GFP
d2EGFP
GFP-mCherry
mCherry
Azami Green
iC3b
C3b
C3
BSA
Protein concentration
Bind iC3b to nitrocellulose filter
Block with BSA
Bind Apt[C3-GFP]
Wash
Bind GFP
Wash
Extract protein
Probe extract with anti-GFP
Immobilized
protein
Apt[C3-GFP]
Non-specific
RNA
GFP
Control
proteins
on gel
+
+       +  +  +
B
S
A
B
S
A
C
3
C
3
b
i
C
3
b
i
C
3
b
G
F
P
C
D
Figure 2. Bi-functional aptamer and formation of the triple complex. (A) Predicted secondary structure of Apt[C3-GFP]. Individual aptamers in the
composite molecule are enclosed in boxes. (B) Binding of Apt[C3-GFP] to C3 (or its derivatives) or GFP (or its derivatives). The ‘low’ and ‘high’
concentrations are 50 and 250nM for the ﬂuorescent proteins, C3b and iC3b; 20 and 100nM for C3; and 500nM and 1mM for BSA. (C) Schematic
diagram of the protocol used to demonstrate triple complex formation. (D) Detection of triple complex formation.
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omitted. In the second type, GFP was replaced with a
ﬂuorescent protein not recognized by AptGFP-AP3. In
these assays the THP-1 cells were maintained as a contin-
uous culture grown in suspension. The cells were
incubated with iC3b, Apt[C3-GFP] and GFP or its deriv-
atives (or combinations of two of these three components
as controls) for 15–30min. Live cells were washed
extensively, and then examined under a microscope.
Figure 3 presents ﬂuorescent microscope images of
non-adherent THP-1 cells at two diﬀerent magniﬁcations
to show representative numbers of GFP-labeled cells and
details of a single cell. In the experimental panels, cells
treated with GFP, iC3b and Apt[C3-GFP] showed a
strong signal for GFP, which was localized in vesicles, in
more than 90% of the cell population. The control panels
showed that in the absence of iC3b, only a weak and
diﬀuse signal was detectable in cells. Neither Azami
Green or mCherry produced ﬂuorescent signals in
THP-1 cells when these proteins were substituted for
GFP. Together these controls conﬁrmed that both the
aptamer and the opsonin iC3b were necessary to
generate the green ﬂuorescent signal.
Aptamer-initiated transportation of extracellular GFP
to lysosomes
Next, we veriﬁed that the opsonization-phagocytosis
pathway was commandeered by the bi-functional
aptamer. To demonstrate that the triple complex (iC3b,
Apt[C3-GFP] and GFP) was responsible for the speciﬁc
uptake of GFP by the phagocytes, we used anti-iC3b
antibody to localize and visualize iC3b molecules
associated with the THP-1 cells. If the bi-functional
aptamer acted as a molecular adaptor, then GFP and
iC3b should co-localize. Indeed, as shown in Figure 4A,
when the images with GFP signals and anti-iC3b signals
were merged, we observed perfect co-localization of the
two. To improve the quality of images for overlay in
this experiment, we used ﬁxed and permeabilized
adherent THP-1 cells that had been stimulated to diﬀer-
entiate by 50ng/ml phorbol myristate acetate. As men-
tioned before, these diﬀerentiated cells mimic native
monocyte-derived macrophages in several aspects (12,13).
Particles are internalized by cells by means of two pri-
mary mechanisms. Small particles (<0.5mm in diameter)
such as macromolecules and viruses enter cells through
receptor-mediated endocytosis, which is a clathrin-based
mechanism. Large particles (>0.5mm) are taken up into
cells by actin-dependent phagocytosis (1). C3b receptors
are involved in both types of internalization (24,25).
Whereas the starting point of this pathway is the cell
surface receptor that recognizes the opsonin, the end
point is the lysosome. We noticed that after incubation
of the cells with iC3b, Apt[C3-GFP] and GFP, green ﬂu-
orescence was concentrated in endosome-like vesicles. To
investigate the identity of these structures, we visualized
GFP using the same experimental setup described above,
and used LysoTracker, an acidophilic dye, to visualize
lysosomes. As shown in Figure 4B, the merged image
showed distinct co-localization of GFP with lysosomes.
Although a low background level of GFP might occur
as a result of nonspeciﬁc endocytosis, here GFP is
strongly and speciﬁcally detectable in the lysosomes, sug-
gesting that we have successfully commandeered the
intended pathway.
Degradation of target molecules in the lysosome
The major objective of commandeering the opsonization-
phagocytosis pathway is down-regulation of target
proteins. However, GFP is a poor subject for investigation
DIC
Experimental (GFP + Apt[C3-GFP] + iC3b)
Control (GFP + Apt[C3-GFP])
GFP
Figure 3. Aptamer-dependent GFP association with unﬁxed THP-1 cells. Representative micrographs of cells at two diﬀerent magniﬁcations, using
diﬀerential interference contrast (DIC) or a green ﬂuorescence ﬁlter. Scale bars indicate 50 and 5mm, respectively. In the experimental panel, cells
were incubated with Apt[C3-GFP], GFP and iC3b. iC3b was omitted in the control. Cells were washed with ice-cold serum-free RPMI medium and
kept on ice before photography.
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reaching lysosomes, because the green ﬂuorescent signals
would be expected to persist for several days in THP-1
cells due to the extraordinary stability of GFP (26–28).
After successfully tracking the path traveled by GFP
even in the harsh environment of lysosomes, we addressed
this issue by employing two GFP derivatives that are
modiﬁed to degrade in a manner more like that of most
other proteins.
First, we used d2EGFP, a destabilized variant of
the enhanced GFP (eGFP) with residues 422–461 of
mouse ornithine decarboxylase (MODC) fused to its
C-terminus (29). This region of the MODC contains a
PEST amino acid sequence that causes rapid protein
turnover (30), and the degradation of d2EGFP correlates
with decay of its ﬂuorescent signal (29). As shown in
Figure 2B, AptGFP-AP3 included in our construct
bound d2EGFP with an aﬃnity similar to that for GFP.
In solution, the ﬂuorescence of d2EGFP is comparable to
that of GFP in the presence or absence of aptamer
binding. However, when d2EGFP was used in our
cell-based assay, the ﬂuorescent signal was barely visible
after incubation, suggesting that the protein has a very
short half-life after uptake by the cells (Figure 5A).
DIC GFP Anti-iC3b Merge
A
B
GFP LysoTracker Merge
Experimental (GFP + Apt[C3-GFP] + iC3b)
Control (GFP + Apt[C3-GFP])
Experimental (GFP + Apt[C3-GFP] + iC3b)
Control (GFP + Apt[C3-GFP])
DIC
Figure 4. Clearance of opsonized particles by the commandeered pathway. (A) Co-localization of GFP with iC3b molecules. iC3b molecules were
visualized using anti-iC3b antibodies. The experimental panel shows cells that were incubated with Apt[C3-GFP], GFP and iC3b. iC3b was omitted
in the control. (B) Co-localization of GFP with lysosomes. Lysosomes were visualized using the LysoTracker dye. The cells in the experimental panel
were incubated with Apt[C3-GFP], GFP, iC3b and Lysotracker. iC3b was omitted in the control. Cells were ﬁxed with 4% paraformaldehyde. Scale
bars in both panels indicate 5mm.
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d2EGFP, we tested another GFP derivative, a
GFP-mCherry fusion protein. In this construct, GFP
is recognized by the aptamer but mCherry is not
(Figure 2B). The two ﬂuorescent proteins are connected
via a peptide linker and function independently. The dual
green and red ﬂuorescent signals of GFP-mCherry
aﬀorded a much more speciﬁc test than d2EGFP, whose
signals quickly disappeared when used as the target for
Apt[C3-GFP]. As shown in Figure 5B, as time elapsed a
gradual dissociation of the two types of ﬂuorescent signals
was observed. Compared to the green signals, the red
signals from mCherry became more diﬀuse and weaker,
indicating that either the peptide linker had been severed
or that mCherry was degraded faster than GFP.
DISCUSSION
The idea of conscripting the complement system for
cancer immunotherapy was proposed more than
20 years ago (31). Complement has a number of advan-
tages over other systems in that it is composed of
A
B
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Fluorescence
Green
Fluorescence
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GFP d2EGFP
Experimental (GFP-MC + Apt[C3-GFP] + iC3b)
Control (GFP-MC + Apt[C3-GFP])
Experimental (GFP-MC + Apt[C3-GFP] + iC3b)
DIC Green
Fluorescence
Red
Fluorescence
Merge
15 minutes
48 hours
Figure 5. Destruction of target molecules in lysosomes. (A) Rapid disappearance of the d2EGFP signal compared to that of GFP. The THP-1 cells
were incubated with Apt[C3-GFP], iC3b and either GFP or d2EGFP. Live cells were photographed as in Figure 3. (B) Bi-color tracking of
GFP-mCherry fusion protein. An early (15min) and a late (48h) stage are shown. Cells in the experimental panel were incubated with
Apt[C3-GFP], GFP-mCherry (GFP-MC) and iC3b. iC3b was omitted in the control. Scale bars in both panels indicate 5mm.
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many of these molecules can be supplied locally by nearby
cells (32,33). Human C3 is the most abundant complement
protein in serum (1.2mg/ml), and low levels of C3b/iC3b
are constitutively available as part of the alternative
pathway of complement activation involved in innate
immune responses (34). At any given time,  0.5% of the
total C3 present in fresh human plasma is in its hydrolyzed
form (6). Normally, opsonization facilitates removal of
antigens from the circulation by macrophages in the
liver and spleen, and by monocytes and neutrophils in
other tissues (35). C3b is preferentially cleared by the com-
plement receptor CR1, and iC3b by CR3 (19). Enhance-
ment of the immune response to targeted proteins via
linkage to C3b has been demonstrated previously
(36–38). On the other hand, aptamers have been widely
used in diagnostic and therapeutic applications (39,40).
RNA constructs containing more than one functional
domain (41) and bi-functional aptamers (42) have also
been reported. Therefore, polyvalent aptamers with high
aﬃnity to both a target and C3b/iC3b could promote
clearance of the target by either CR1 or CR3. If the
target is on the surface of a cancer cell, aptameric
adaptors could increase the deposition of C3b/iC3b on
the cell and promote adhesion of eﬀector cells such as
macrophages and NK cells through complement recep-
tors, whereby cytotoxicity may ensue with the help of
additional signals (43–45).
In vivo implementation of the principle proved here
would require several modiﬁcations to our prototype
aptameric adaptor, among which two are most important.
First, our current bi-functional aptamers are natural RNA
molecules. Without chemical modiﬁcation they are labile
in the extracellular environment. Second, as a shortcut, we
used C3 as the target to select aptamers that would not be
inhibitory to C3b/iC3b activity; however, aptamers to be
used in vivo should bind only opsonins, i.e. C3b and/or
iC3b, but not C3. Otherwise, C3 might ‘soak up’ these
aptamers. We plan to address these and other issues in
the next stage of development. In particular, we will
perform additional in vitro selection experiments to
identify aptamers in the form of modiﬁed RNA, such as
20ﬂuoro-pyrimidine RNA. This type of aptamer is more
stable in vivo, with a half-life up to 80h in serum (46).
We have previously demonstrated that aptamers can
be isolated for discrete sites on a protein (18). When
aptamers recognizing diﬀerent areas of the C3b/iC3b
surface are isolated, some of them may not interfere
with any known activity of these molecules and would
be ideal for our purpose. A one-time optimization of the
aptamer-C3b/iC3b interface will generate a generic utility
moiety, which can be connected with any targeting
aptamer using a general method we developed (47) to
form diverse and speciﬁc opsonizing adaptors.
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